Stem cell startup proclaims ‘inflection point’ for medicine as mass production nears
Swedish biotech Cellcolabs believes stem cell therapies are approaching commerci...
Can Europe’s AI rules turn worker protections into a competitive edge?
As artificial intelligence threatens jobs across Europe, lawmakers face pressure...
